Anthocyanins
- 2 independent labs in 2 countries
- Funders: Department of Agriculture, Environment and Rural Affairs, UK Government and 4 more
- Humans1
Outcomes
5Inflammation
downin humans1
1 study
Inflammation
downin humans1
Anthocyanins decrease inflammation in humans.
Review
Dietary anthocyanins and the MAPK signaling pathway: from food sources to molecular mechanisms
Food research international (Ottawa, Ont.)6 Jul 2026
Senescence-associated secretory phenotype (SASP)
downin reviews1
1 study
Senescence-associated secretory phenotype (SASP)
downin reviews1
Anthocyanins inhibit senescence-associated secretory phenotype (SASP).
Review
Dietary anthocyanins and the MAPK signaling pathway: from food sources to molecular mechanisms
Food research international (Ottawa, Ont.)6 Jul 2026
Insulin
downin humans1
1 study
Insulin
downin humans1
Anthocyanins decrease insulin in humans (-2.24 pmol/L (95% CI: -4.22, -0.27)).
Reviewhealthy participants≥1 d
The American journal of clinical nutrition18 Jun 2026
Flow-mediated dilation
upin humans1
1 study
Flow-mediated dilation
upin humans1
Anthocyanins improve flow-mediated dilation in humans (net change: 1.41% (95% CI: 0.90%, 1.91%)).
Reviewhealthy participants≥1 d
The American journal of clinical nutrition18 Jun 2026
Mortality
downin humans1−9% risk reduction
1 study
Mortality
downin humans1−9% risk reduction
Anthocyanins decrease mortality in humans (9% risk reduction).
Reviewhighest compared with lowest habitual intake
The American journal of clinical nutrition18 Jun 2026
Associations
2Stroke
downin humans1OR 0.69
1 study
Stroke
downin humans1OR 0.69
Anthocyanins lower the risk of stroke in humans (OR = 0.69; 95% CI: 0.48, 0.98).
Humans
Medicine14 Aug 2026
Cardiovascular disease
downin humans1−26% risk reduction
1 study
Cardiovascular disease
downin humans1−26% risk reduction
Anthocyanins lower the risk of cardiovascular disease in humans (26% risk reduction).
Reviewhighest compared with lowest habitual intake
The American journal of clinical nutrition18 Jun 2026